NEOTIGASON caps 25 mg 30 pce
7680492270353
CH-49227
D05BB02
10.03.0.
Reimbursement limitations:
NEOTIGASON
Cas graves, réfractaires à la thérapeutique de psoriasis et de dyskératoses.
1 / 3
google
Details
- Product number
- 4922702
- CPT
- -
- Packaging group
- 30
- Unit
- Kapsel(n)
- Composition
- acitretinum 25 mg, glucosum liquidum dispersione desiccatum 41 mg, gelatina, cellulosum microcristallinum, natrii ascorbas corresp. natrium 0.8 mg, Kapselhülle: gelatina, E 171, E 172, Drucktinte: lacca, propylenglycolum, ammonii hydroxidum, E 172, pro capsula.
Articles (1)
Neotigason 25 mg, Kapseln
Kapseln
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
25.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
41.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.8 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 81.50
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
15/03/1992
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 49227
- Drug name
- Neotigason, Kapseln
- Galenic form
- KAHA
- ATC Code
- D05BB02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 19/03/1990
- Authorization expiration date
- 31/12/9999
- IT number
- 10.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NEOTIGASON caps 25 mg 30 pce
- Description (DE)
- NEOTIGASON Kaps 25 mg 30 Stk
- Market launch
- 19/03/1990
- Narcotic (BTM)
- No